Related Experiment Video
Updated: Oct 22, 2025
07:01
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.2K
Attitudes toward epilepsy in Indonesia.
Gunadharma Suryani1, Seilly Yunita Jehosua2, Khosama Herlyani2
1Department of Neurology, Faculty of Medicine, University of Padjajaran/Hasan Sadikin Hospital, Bandung, Indonesia.
Epilepsy & Behavior : E&B
|August 30, 2021
Summary
Javanese Indonesians exhibit poorer attitudes toward epilepsy compared to Minahasan and Sundanese groups. These differences in epilepsy perception may stem from socioeconomic or cultural factors.
Area of Science:
- Neurology
- Sociology
- Cultural Studies
Background:
- Indonesia, the world's largest island nation, features significant ethnic and cultural diversity.
- Understanding variations in public attitudes toward epilepsy across different Indonesian ethnic groups is crucial.
Purpose of the Study:
- To investigate and compare attitudes toward epilepsy among the Javanese, Sundanese, and Minahasa ethnic groups in Indonesia.
- To identify potential socioeconomic or cultural influences on these attitudes.
Main Methods:
- The Indonesian Public Attitudes Toward Epilepsy (PATE) scale was administered to Sundanese (Tasikmalaya) and Minahasan (Manado) participants.
- Results were compared with existing data from Javanese and Malaysian populations.
Main Results:
- A total of 200 respondents (mean age 38.51 years, 54% female) participated.
- Javanese individuals demonstrated significantly poorer attitudes toward epilepsy, particularly concerning education, marital relationships, and employment.
- No significant differences in attitudes were found between Minahasan, Sundanese, and Malaysian groups.
Conclusions:
- Epilepsy attitudes in Indonesia (Minahasan, Sundanese) align with those in Malaysia, with the Javanese population showing notably poorer attitudes.
- Socioeconomic and cultural factors likely contribute to the observed differences in epilepsy perception among the Javanese.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
385
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
385
01:13Seizures: Classification
706
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
706
01:30Electroconvulsive Therapy
285
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
285
01:20Antiepileptic Drugs: Potassium Channel Activators
372
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
372
01:14Antiepileptic Drugs: Glutamate Antagonists
604
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
604
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
822
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
822